143 related articles for article (PubMed ID: 27357543)
41. Scalable Production of Recombinant Membrane Active Peptides and Its Potential as a Complementary Adjunct to Conventional Chemotherapeutics.
Rothan HA; Ambikabothy J; Abdulrahman AY; Bahrani H; Golpich M; Amini E; A Rahman N; Teoh TC; Mohamed Z; Yusof R
PLoS One; 2015; 10(9):e0139248. PubMed ID: 26418816
[TBL] [Abstract][Full Text] [Related]
42. Novel production method of innovative antiangiogenic and antitumor small peptides in
Setrerrahmane S; Yu J; Hao J; Zheng H; Xu H
Drug Des Devel Ther; 2017; 11():3207-3220. PubMed ID: 29184391
[TBL] [Abstract][Full Text] [Related]
43. 4-Methylumbelliferones Analogues as Anticancer Agents: Synthesis and in Cell Pharmacological Studies.
Huang RZ; Hua SX; Wang CY; Pan YM; Qin JM; Ding ZY; Zhang Y; Wang HS
Anticancer Agents Med Chem; 2017; 17(4):576-589. PubMed ID: 27671299
[TBL] [Abstract][Full Text] [Related]
44. Peptides extracted from edible mushroom: Lentinus squarrosulus induces apoptosis in human lung cancer cells.
Prateep A; Sumkhemthong S; Suksomtip M; Chanvorachote P; Chaotham C
Pharm Biol; 2017 Dec; 55(1):1792-1799. PubMed ID: 28532227
[TBL] [Abstract][Full Text] [Related]
45. [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells].
Liu Y; Chen X; Luo Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):592-6. PubMed ID: 24909280
[TBL] [Abstract][Full Text] [Related]
46. Biologic activities of recombinant human-beta-defensin-4 toward cultured human cancer cells.
Gerashchenko OL; Zhuravel EV; Skachkova OV; Khranovska NN; Filonenko VV; Pogrebnoy PV; Soldatkina MA
Exp Oncol; 2013 Jun; 35(2):76-82. PubMed ID: 23828379
[TBL] [Abstract][Full Text] [Related]
47. From a pro-apoptotic peptide to a lytic peptide: One single residue mutation.
Zhou XR; Zhang Q; Tian XB; Cao YM; Liu ZQ; Fan R; Ding XF; Zhu Z; Chen L; Luo SZ
Biochim Biophys Acta; 2016 Aug; 1858(8):1914-25. PubMed ID: 27207743
[TBL] [Abstract][Full Text] [Related]
48. Influence of a novel histone deacetylase inhibitor panobinostat (LBH589) on the growth of ovarian cancer.
Garrett LA; Growdon WB; Rueda BR; Foster R
J Ovarian Res; 2016 Sep; 9(1):58. PubMed ID: 27633667
[TBL] [Abstract][Full Text] [Related]
49. Functionalization of peptide nucleolipid bioconjugates and their structure anti-cancer activity relationship studies.
Rana N; Cultrara C; Phillips M; Sabatino D
Bioorg Med Chem Lett; 2017 Sep; 27(17):4019-4023. PubMed ID: 28789897
[TBL] [Abstract][Full Text] [Related]
50. Icariin regulates the proliferation and apoptosis of human ovarian cancer cells through microRNA-21 by targeting PTEN, RECK and Bcl-2.
Li J; Jiang K; Zhao F
Oncol Rep; 2015 Jun; 33(6):2829-36. PubMed ID: 25845681
[TBL] [Abstract][Full Text] [Related]
51. Asiatic acid exerts anticancer potential in human ovarian cancer cells via suppression of PI3K/Akt/mTOR signalling.
Ren L; Cao QX; Zhai FR; Yang SQ; Zhang HX
Pharm Biol; 2016 Nov; 54(11):2377-2382. PubMed ID: 26984021
[TBL] [Abstract][Full Text] [Related]
52. Pro-apoptotic effect and cytotoxicity of genistein and genistin in human ovarian cancer SK-OV-3 cells.
Choi EJ; Kim T; Lee MS
Life Sci; 2007 Mar; 80(15):1403-8. PubMed ID: 17291540
[TBL] [Abstract][Full Text] [Related]
53. [Effects of ARLTS1 gene on growth and apoptosis of epithelial ovarian cancer SKOV3 cells].
Yang XY; Yu H; Lin W; Peng ZL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 40(1):6-10. PubMed ID: 19292033
[TBL] [Abstract][Full Text] [Related]
54. Orlistat, a novel potent antitumor agent for ovarian cancer: proteomic analysis of ovarian cancer cells treated with Orlistat.
Huang HQ; Tang J; Zhou ST; Yi T; Peng HL; Shen GB; Xie N; Huang K; Yang T; Wu JH; Huang CH; Wei YQ; Zhao X
Int J Oncol; 2012 Aug; 41(2):523-32. PubMed ID: 22581080
[TBL] [Abstract][Full Text] [Related]
55. Benzethonium chloride: a novel anticancer agent identified by using a cell-based small-molecule screen.
Yip KW; Mao X; Au PY; Hedley DW; Chow S; Dalili S; Mocanu JD; Bastianutto C; Schimmer A; Liu FF
Clin Cancer Res; 2006 Sep; 12(18):5557-69. PubMed ID: 17000693
[TBL] [Abstract][Full Text] [Related]
56. [Effects of selected phages with specific peptide ligands on the biological behaviors of ovarian cancer cells].
Wang SX; Ma XY; Zhou HY; Chen G; He FX; Lu YP; Ma D
Zhonghua Fu Chan Ke Za Zhi; 2005 Oct; 40(10):685-8. PubMed ID: 16277901
[TBL] [Abstract][Full Text] [Related]
57. Expression and activity analysis of a new fusion protein targeting ovarian cancer cells.
Su M; Chang W; Wang D; Cui M; Lin Y; Wu S; Xu T
Oncol Rep; 2015 Sep; 34(3):1337-44. PubMed ID: 26166362
[TBL] [Abstract][Full Text] [Related]
58. Expression and role of the inhibitor of apoptosis protein livin in chemotherapy sensitivity of ovarian carcinoma.
Liu X; Wang A; Gao H; Yuan Z; Jiao Y
Int J Oncol; 2012 Sep; 41(3):1021-8. PubMed ID: 22766624
[TBL] [Abstract][Full Text] [Related]
59. Ovarian cancer targeted hyaluronic acid-based nanoparticle system for paclitaxel delivery to overcome drug resistance.
Wang L; Jia E
Drug Deliv; 2016 Jun; 23(5):1810-7. PubMed ID: 26530693
[TBL] [Abstract][Full Text] [Related]
60. Synthesis and anticancer activity of some novel 2-phenazinamine derivatives.
Gao X; Lu Y; Fang L; Fang X; Xing Y; Gou S; Xi T
Eur J Med Chem; 2013 Nov; 69():1-9. PubMed ID: 23995213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
